Warner A E
Arthritis Rheum. 2001 Aug;44(8):1959-61. doi: 10.1002/1529-0131(200108)44:8<1959::AID-ART334>3.0.CO;2-A.
This report describes the case of an appropriately dosed patient who developed maculopathy <8 years after starting hydroxychloroquine (HCQ) therapy for systemic lupus erythematosus. Risk factors and screening for HCQ-associated maculopathy are discussed.
本报告描述了一名系统性红斑狼疮患者在开始使用羟氯喹(HCQ)治疗后不到8年就出现黄斑病变的病例。文中讨论了HCQ相关黄斑病变的危险因素及筛查方法。